454 Life Sciences Unveils New Bench Top Sequencer, Significant Improvements to the Genome Sequencer FLX System Including 1,000 bp Reads for 2010

BRANFORD, Conn.--(BUSINESS WIRE)--454 Life Sciences, a Roche Company (SWX:RO) (SWX:ROG) (Pink Sheets: RHHBY), announced today at the Association of Molecular Pathology Annual Meeting in Kissimmee, Florida a series of revolutionary developments which significantly expand the company’s high-throughput sequencing portfolio. Addressing the growing demand for next-generation sequencing data in everyday biological and clinical research, the company revealed the new GS Junior System, an affordable bench top sequencing platform slated for release in 2010.

MORE ON THIS TOPIC